Search

everythinglearnresearchcommunity

for

Search:↓

Zolpidem shows up in hair from the top back of the head after one dose and fades over time, suggesting it gets into hair through blood and sweat.

A new minoxidil-like substance, triaminodil, was found in an illegal hair growth supplement.

The new method is rapid, sensitive, and accurate for evaluating the quality of the medicinal herb Platycladi cacumen.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

A new method accurately measures amino acids in treated hair, showing bleaching reduces amino acids while protein treatments increase them.

New method measures finasteride in plasma, finds two formulations bioequivalent.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The method detected sex hormones in some health supplements, with one containing banned testosterone.

Biotin helps regulate proteins in the blood, which may explain its role in hair growth.

A new, quick method was developed to analyze skin lipids, discovering a new ceramide subclass.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

New method measures finasteride in blood quickly and accurately.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Researchers developed a method to measure plant compounds in rat blood and found they are quickly absorbed and eliminated within 36 hours.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

Both HPSAM and PLS methods accurately measure minoxidil and tretinoin concentrations.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Finasteride may lower cholesterol and slow heart disease progression.